A Call to Arms: Economic Barriers to Optimal Dialysis Care

Epidemic growth rates and the enormous cost of dialysis pressure end-stage renal disease (ESRD) delivery systems around the world. Payers of dialysis services can constrain costs through (1) limiting access to dialysis, (2) reducing the quality of dialysis, and (3) placing constraints on modality distribution. In order to secure the necessary resources for ESRD care, we propose that the nephrology community consider the following suggestions: First, future leaders in dialysis should acquire additional advanced training in innovative pathways such as health care economics, business and health care administration, and health care policy. Second, the international nephrology community must strongly engage in ongoing advocacy for accessible, high quality, cost-effective care. Third, efforts should be made to better define and then implement optimal dialysis modality distributions that maximize patient outcomes but limit unnecessary costs. Fourth, industry should be encouraged to lower the unit cost of dialysis, allowing for improved access to dialysis, especially in developing countries. Fifth, research should be encouraged that seeks to identify measures that will reduce dialysis costs but will not impair quality of care. Finally, early referral of patients with progressive renal disease to nephrology clinics, empowerment of informed patient choice of dialysis modality, and proper and timely access creation should be encouraged and can be expected to help limit overall expenditures. Ongoing efforts in these areas by the nephrology community will be essential if we are to overcome the challenges of ESRD growth in this new decade.

[1]  D. Mendelssohn,et al.  Dialysis utilization in the Toronto region from 1981 to 1992. Toronto Region Dialysis Committee. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[2]  R. Chesney,et al.  Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement , 1994, Annals of Internal Medicine.

[3]  W. van Biesen,et al.  The Referral Pattern of Patients with Esrd is a Determinant in the Choice of Dialysis Modality , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  A. Kausz,et al.  Pre-end-stage renal disease care in the United States: a state of disrepair. , 1998, Journal of the American Society of Nephrology : JASN.

[5]  A. Eddleston,et al.  Negative selection of patients for dialysis and transplantation in the United Kingdom. , 1984, British medical journal.

[6]  N. Levinsky Quality and equity in dialysis and renal transplantation. , 1999, The New England journal of medicine.

[7]  A. Nissenson,et al.  Non-medical factors that impact on ESRD modality selection. , 1993, Kidney international. Supplement.

[8]  J. Yudkin,et al.  Proteinuria and progressive renal disease: birth weight and microalbuminuria. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  M Diener-West,et al.  Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. , 1999, The New England journal of medicine.

[10]  R. Mehta,et al.  Attitudes of Canadian Nephrologists toward Dialysis Modality Selection , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  S. Prichard Treatment Modality Selection in 150 Consecutive Patients Starting Esrd Therapy , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  A. Nissenson,et al.  ESRD modality selection into the 21st century: the importance of non medical factors. , 1997, ASAIO journal.

[13]  C. Winearls Successful treatment of middle aged and elderly patients with end stage renal disease. , 1983, British medical journal.

[14]  S. Draibe,et al.  Acceptance for chronic dialysis treatment: insufficient and unequal. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  W. van Biesen,et al.  End-stage renal disease treatment: a European perspective. , 1998, Journal of the American Society of Nephrology : JASN.

[16]  S. Schwab Improving access patency: pre-end-stage renal disease strategies. , 1998, Journal of the American Society of Nephrology : JASN.

[17]  N. Levinsky The organization of medical care. Lessons from the Medicare end stage renal disease program. , 1993, The New England journal of medicine.

[18]  M. Rocco,et al.  The costs of hospitalizations due to hemodialysis access management. , 1995, Nephrology news & issues.

[19]  K. Nolph,et al.  Socioeconomic Aspects of Peritoneal Dialysis in North America: Role of Non Medical Factors in the Choice of Dialysis , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[20]  E. Cooper,et al.  1999 Annual Report , 2000 .

[21]  R. Wolfe,et al.  Patterns of low incidence of treated end-stage renal disease among the elderly. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  J. Iglehart The American health care system. The End Stage Renal Disease Program. , 1993, The New England journal of medicine.

[23]  F. Quarello,et al.  Elderly patients on dialysis: epidemiology of an epidemic. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  A. Collins,et al.  Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993. , 1998, Journal of the American Society of Nephrology : JASN.

[25]  M. Rao,et al.  Haemodialysis for end-stage renal disease in Southern India--a perspective from a tertiary referral care centre. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  R. Wolfe,et al.  A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. , 1995, Journal of the American Society of Nephrology : JASN.

[27]  J. Iglehart,et al.  The American health care system. Managed care. , 1992, The New England journal of medicine.

[28]  S. Garella Pathophysiology and clinical implications of proteinuria. , 1990, Nephrology, Dialysis and Transplantation.

[29]  R. Wolfe,et al.  A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. , 1995, Journal of the American Society of Nephrology : JASN.

[30]  S. Mittal,et al.  Chronic renal failure in India. , 1997, Renal failure.

[31]  Everett M. Rogers,et al.  Consensus Development Conference , 1984 .

[32]  P. Blake Factors Affecting International Utilization of Peritoneal Dialysis: Implications for Increasing Utilization in the United States , 1999 .

[33]  S. Garella The costs of dialysis in the USA. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  J. Berlin,et al.  Hemodialysis vascular access morbidity in the United States. , 1993, Kidney international.

[35]  B. Pereira,et al.  Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  I. Cheng Peritoneal Dialysis in Asia , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[37]  F. Port,et al.  The dose of hemodialysis according to dialysis prescription in Europe and the United States. , 1992, Kidney international. Supplement.

[38]  P. Singer,et al.  Referral for dialysis in Ontario. , 1995, Archives of internal medicine.

[39]  D. Marcelli,et al.  Dialysis patient outcomes in Europe vs the USA. Why do Europeans live longer? , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  M. Saul,et al.  The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. , 1998, Journal of the American Society of Nephrology : JASN.

[41]  H. Morrison,et al.  Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.